@NaanDerthaal @TheSGEM @RozehnalMd @bmj_latest Ok, so on average a gain of 0.16 QALY annually over 5 years. That’s good (again, I don’t have anything against THAs) HAART vs untreated HIV is an improvement of 0.29 QALY annually https://t.co/KY8UsUDtTK
Economic Evaluation of Initial ART for HIV+ Pts - Update of Italian Guidelines http://t.co/hzNf092WJk HT @unipv http://t.co/doQTl45mAJ
Economic Evaluation of Initial ART for HIV+ Pts - Update of Italian Guidelines http://t.co/gQpwqRGFCM HT @unipv http://t.co/p4KdM1e0IB
Economic Evaluation of Initial ART for HIV+ Pts - Update of Italian Guidelines http://t.co/hzNf092WJk HT @unipv http://t.co/doQTl45mAJ
Economic Evaluation of Initial ART for HIV+ Pts - Update of Italian Guidelines http://t.co/gQpwqRGFCM HT @unipv http://t.co/p4KdM1e0IB
#Economic evaluation of initial #HIV treatment - #Italian study but helpful globally http://t.co/XFGU0T7Rft
Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines http://t.co/RCsIVIU2pg